Subcutaneous_lidocaine_for_treatment_of_neuropathic_cancer_pain._Three_patients_with_terminal_malignancy_reporting_ineffective_analgesia_using_systemic_and_subsequently_spinal_opiates_were_treated_with_subcutaneous_infusion_of_10%_lidocaine_hydrochloride._During_the_infusion,_reasonably_stable_blood_concentrations_were_achieved_and_maintained_using_a_subcutaneous_infusion_at_varying_dose_rates_over_days_to_months_with_improvement_of_the_pain_complaints_which_continued_to_be_refractory_to_conventional_analgesics._Blood_lidocaine_levels_obtained_at_regular_intervals_revealed_effective_concentrations_between_2_and_5_micrograms/ml_for_each_patient.